[Coagulation/fibrinolysis disorders in the elderly]

A Deguchi1, H Wada, H Shiku

  • 1Oyamada Memorial Spa Hospital, Yokkaichi.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 11, 2000
PubMed

Insights

Establishing new reference intervals for hemostatic tests in the elderly is crucial. Current intervals, based on young adults, do not accurately reflect coagulation and fibrinolysis in older individuals.

Area of Science:

  • Gerontology
  • Hematology
  • Clinical Chemistry

Background:

  • Hemostatic test interpretation in the elderly is challenging due to age-related physiological changes.
  • Existing reference intervals are typically derived from younger, healthy populations, potentially leading to misdiagnosis in older adults.

Purpose of the Study:

  • To establish age-specific reference intervals for hemostatic tests in elderly individuals.
  • To investigate age-related differences in coagulation and fibrinolysis markers in the elderly.
  • To assess the suitability of proposed elderly reference intervals for diagnosing disseminated intravascular coagulation.

Main Methods:

  • 11 hemostatic tests were performed on 120 elderly individuals (average age 78.6 years).
  • Participants were community-dwelling, ambulatory, and independent in daily living.
  • Statistical analyses included Wilcoxon tests and correlation coefficients to compare age groups and age with test values.

Main Results:

  • Most hemostatic test results (25.8%–93.3%) deviated from young adult reference intervals.
  • Fibrinolysis appeared more activated than coagulation in the elderly cohort.
  • Separate reference intervals are recommended for early elderly (65–74 years) and late elderly (≥75 years) for antithrombin III, protein C, D-dimer, and thrombomodulin.

Conclusions:

  • Standard reference intervals for hemostatic tests are inadequate for the elderly population.
  • Age-specific reference intervals are necessary for accurate interpretation of hemostatic function in older adults.
  • The proposed reference intervals support the diagnosis of disseminated intravascular coagulation in the elderly.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...